AC gas bubbles do not affect corneal endothelial cell density in LASIK procedures

Article

Anterior chamber (AC) gas bubbles do not affect corneal endothelial cell density (ECD) during flap creation in LASIK operations.

Anterior chamber (AC) gas bubbles do not affect corneal endothelial cell density (ECD) during flap creation in LASIK operations, according to a study featured in the European Journal of Ophthalmology.

A team led by Dr Minoru Tomita, Shinagawa LASIK Center, Tokyo, Japan, conducted myopic LASIK in 436 eyes of 252 patients. For flap creation the IntraLase FS30 was used and Akkgretto Wave Eye-Q was used to perform excimer laser ablation. The ECD was measured pre-operatively and 3-month postoperatively. These were measured and compared using a noncontact specular microscope. Changes in ECD were compared to the group that did not have AC gas bubbles.

The study findings demonstrated that the average ECD reduction post-LASIK was –15±102 cells/mm2 for eyes without AC gas bubbles and –35±130 cells/mm2 for eyes with AC gas bubbles. There were no significant changes in ECD between either groups.

It was also concluded that using Intralase FS30 is a safe and successful way to complete LASIK operations and does not damage ECD.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.